+218.1%
MRNA vs CSGP
-60.9%
+279.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CSGP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +2.9% | -6.3% | -5.3% |
| 7D | -12.1% | +1.3% | -13.5% | -12.8% |
| 30D | -1.3% | +2.8% | -4.1% | -7.4% |
| 3M | +250.9% | -6.3% | +257.3% | +259.3% |
| 6M | +343.0% | -3.2% | +346.2% | +340.0% |
| YTD | +657.4% | -54.0% | +711.4% | +975.7% |
| 1Y | +794.9% | -54.8% | +849.7% | +1,182.4% |
| 3Y | +218.1% | -60.6% | +278.7% | +363.9% |
| All | +218.1% | -60.9% | +279.1% | +363.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CSGP.
Daily Out/Under-Performance
Portfolio return minus CSGP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CSGP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CSGP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling